Avoiding obstacles when outsourcing your nonclinical research

June 10, 2020 | 11:00am CDT

Avoiding obstacles when outsourcing your nonclinical research webinar

In biopharmaceutical development, demonstrating efficacy and toxicity is a major milestone to entering human clinical trials. Most companies lack the internal resources to support all of their nonclinical development needs, relying on outsourcing some or all aspects of their program to nonclinical CROs. Knowing the technical challenges involved in outsourcing your program plays a critical role in bringing your drug to market and can mean the difference between meeting your next milestone on time or experiencing delays.

On June 10, Sinclair's Senior Vice President of Research and Operations, Scott E. Boley, PhD, DABT, will share insight on how to plan for obstacles drug developers will face in outsourcing nonclinical research and how to avoid critical missteps that can affect your program and timeline.

In this webinar you will learn:

Register for the webinar